-
1 Comment
MPX International Corporation is currently in a long term downtrend where the price is trading 17.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.
MPX International Corporation's total revenue rose by 210.0% to $2M since the same quarter in the previous year.
Its net income has increased by 49.2% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 80.8% to $-1M since the same quarter in the previous year.
Based on the above factors, MPX International Corporation gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers-Specialty & Generic |
| ISIN | CA55344L1022 |
| CurrencyCode | EUR |
| Exchange | F |
| Market Cap | 72K |
|---|---|
| Beta | 0.8 |
| Dividend Yield | 0.0% |
| Target Price | None |
| PE Ratio | None |
MPX International Corporation, a cannabis company, focuses on the medical and adult-use cannabis markets in Canada and Switzerland. It is involved in producing and distributing three types of products, such as cannabis flowers, cannabis extract and related products, and cannabis derivatives under the Strain Rec and Salus BioPharma brands. The company was founded in 2015 and is headquartered in Toronto, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2J6.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
